{"transactions":[{"id":1238979,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-01T00:30:06.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares were fully vested and exercisable as of March 3, 2015, the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-25-006069","document":"form4-02282025_070201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006069/form4-02282025_070201.xml","form_type":"4"}},{"id":1238978,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T00:30:06.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":750,"price":1.39,"value":1042.5,"ownership":{"direct":true},"balance_after":57606,"source":{"system":"sec-edgar","filing":"0001415889-25-006069","document":"form4-02282025_070201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006069/form4-02282025_070201.xml","form_type":"4"}},{"id":1311423,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:09.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000868","document":"form4-01062025_070105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000868/form4-01062025_070105.xml","form_type":"4"}},{"id":1311422,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:09.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":3240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":3240,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":3240},"source":{"system":"sec-edgar","filing":"0001415889-25-000868","document":"form4-01062025_070105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000868/form4-01062025_070105.xml","form_type":"4"}},{"id":1311421,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:09.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000868","document":"form4-01062025_070105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000868/form4-01062025_070105.xml","form_type":"4"}},{"id":1535568,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-25T13:15:08.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vested 1/48th of the first day of each month, commencing March 1, 2020."}],"balance_after":53000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-24-011488","document":"form4-04252024_090402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011488/form4-04252024_090402.xml","form_type":"4"}},{"id":1535567,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-25T13:15:08.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":1.39,"value":41700.0,"ownership":{"direct":true},"balance_after":56856,"source":{"system":"sec-edgar","filing":"0001415889-24-011488","document":"form4-04252024_090402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011488/form4-04252024_090402.xml","form_type":"4"}},{"id":1688583,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:22.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":14280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service."}],"balance_after":14280,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":14280},"source":{"system":"sec-edgar","filing":"0001415889-24-000652","document":"form4-01042024_050110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000652/form4-01042024_050110.xml","form_type":"4"}},{"id":1688582,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:22.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":8030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service."}],"balance_after":8030,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":8030},"source":{"system":"sec-edgar","filing":"0001415889-24-000652","document":"form4-01042024_050110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000652/form4-01042024_050110.xml","form_type":"4"}},{"id":1688581,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:22.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":29250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":29250,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":29250},"source":{"system":"sec-edgar","filing":"0001415889-24-000652","document":"form4-01042024_050110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000652/form4-01042024_050110.xml","form_type":"4"}},{"id":1761258,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-12T13:15:07.000Z","date":"2023-10-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.83,"value":28300.0,"ownership":{"direct":true},"balance_after":26856,"source":{"system":"sec-edgar","filing":"0001415889-23-014099","document":"form4-10122023_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923014099/form4-10122023_091001.xml","form_type":"4"}},{"id":2013898,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-16T01:00:17.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vested immediately, with the remainder vesting monthly over 25 months commencing May 1, 2013."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001415889-23-002649","document":"form4-02152023_080201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923002649/form4-02152023_080201.xml","form_type":"4"}},{"id":2013897,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T01:00:17.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":1401,"price":1.39,"value":1947.39,"ownership":{"direct":true},"balance_after":16856,"source":{"system":"sec-edgar","filing":"0001415889-23-002649","document":"form4-02152023_080201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923002649/form4-02152023_080201.xml","form_type":"4"}},{"id":2063286,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:00:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board service."}],"balance_after":19000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-23-000593","document":"form4-01052023_080132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000593/form4-01052023_080132.xml","form_type":"4"}},{"id":2063285,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:00:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":11870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board committee service."}],"balance_after":11870,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":11870},"source":{"system":"sec-edgar","filing":"0001415889-23-000593","document":"form4-01052023_080132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000593/form4-01052023_080132.xml","form_type":"4"}},{"id":2063284,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:00:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":37770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2023, with the last month vesting on December 31, 2023, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":37770,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":37770},"source":{"system":"sec-edgar","filing":"0001415889-23-000593","document":"form4-01052023_080132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000593/form4-01052023_080132.xml","form_type":"4"}},{"id":2342335,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-10T00:00:13.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":15455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vested immediately, with the remainder vesting 1/36th of the first day of each month commencing June 1, 2012."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":15455},"source":{"system":"sec-edgar","filing":"0001415889-22-002812","document":"form4-03092022_070302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922002812/form4-03092022_070302.xml","form_type":"4"}},{"id":2342334,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T00:00:13.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":15455,"price":1.39,"value":21482.45,"ownership":{"direct":true},"balance_after":15455,"source":{"system":"sec-edgar","filing":"0001415889-22-002812","document":"form4-03092022_070302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922002812/form4-03092022_070302.xml","form_type":"4"}},{"id":2450292,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T02:00:39.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":63060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":63060,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":63060},"source":{"system":"sec-edgar","filing":"0001415889-22-000278","document":"form4-01042022_090129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922000278/form4-01042022_090129.xml","form_type":"4"}},{"id":2916312,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T22:03:09.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":71951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the\noption can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be\nsubject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":71951,"derivative":{"exercise_price":3.74,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":71951},"source":{"system":"sec-edgar","filing":"0001104659-21-001584","document":"tm211849-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465921001584/tm211849-3_4seq1.xml","form_type":"4"}},{"id":3116935,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T20:33:57.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing March 1, 2020, until the stock option becomes fully vested and exercisable.  The following stock option grant was approved by the Board on February 12, 2020 under the 2020 Plan, contingent upon stockholder approval of the 2020 Plan, which was obtained on June 5, 2020. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":83000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001104659-20-071417","document":"tm2022128-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920071417/tm2022128-3_4.xml","form_type":"4"}},{"id":3271114,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":15455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":15455},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271113,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":1401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271112,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":57.8,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271111,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":2437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":31.2,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":2437},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271110,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":2856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"856 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 2,000 shares will vest 1/12th on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":0,"derivative":{"exercise_price":25.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":2856},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271109,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":3050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1,050 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable.  The remaining 2,000 shares will vest 1/12th on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":0,"derivative":{"exercise_price":15.7,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271108,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,000 of the shares were vested on the date of grant. The remaining 1,750 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":0,"derivative":{"exercise_price":3.25,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271107,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":15455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":15455,"derivative":{"exercise_price":1.39,"expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":15455},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271106,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":1401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":1401,"derivative":{"exercise_price":1.39,"expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271105,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":750,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271104,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":2437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":2437,"derivative":{"exercise_price":1.39,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":2437},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271103,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":2856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"856 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 2,000 shares will vest 1/12th on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":2856,"derivative":{"exercise_price":1.39,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":2856},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271102,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":3050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1,050 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable.  The remaining 2,000 shares will vest 1/12th on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":3050,"derivative":{"exercise_price":1.39,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3271101,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,000 of the shares were vested on the date of grant. The remaining 1,750 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":4750,"derivative":{"exercise_price":1.39,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001104659-20-022100","document":"tm208086d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/tm208086d3_4.xml","form_type":"4"}},{"id":3442565,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-10T01:00:20.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,000 of the shares shall vest immediately. The remaining 1,750 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":4750,"derivative":{"exercise_price":3.25,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001144204-19-038999","document":"tv527330_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420419038999/tv527330_form4.xml","form_type":"4"}},{"id":3690647,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":7209,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":46.89,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":7209},"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3690646,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":149.22,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3690645,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":47.27,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3690644,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":60.77,"expiration_date":"2025-06-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3690643,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":26.36,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3690642,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Restricted Stock Units","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":4052,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4052},"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3690641,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-22T09:56:05.000Z","date":"2019-01-22","kind":"other","acquired":false,"shares":2090,"price":75,"value":156750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation (\"Purchaser\") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales (\"Parent\"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation (\"TESARO\"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the \"Merger Agreement\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001123292-19-000164","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000164/edgar.xml","form_type":"4"}},{"id":3905303,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Restricted Stock Units","published_at":"2018-06-05T17:07:13.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":4052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest on the earlier of the one-year anniversary of the date of grant and the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest on the earlier of the one-year anniversary of the date of grant and the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":4052,"derivative":{"underlying":"Common Stock","underlying_shares":4052},"source":{"system":"sec-edgar","filing":"0001104659-18-038343","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918038343/a4.xml","form_type":"4"}},{"id":3905302,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2018-06-05T17:07:13.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":7209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of the one-year anniversary of the date of grant and the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":7209,"derivative":{"exercise_price":46.89,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":7209},"source":{"system":"sec-edgar","filing":"0001104659-18-038343","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918038343/a4.xml","form_type":"4"}},{"id":3905301,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T17:07:13.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":1631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person has elected to receive TESARO common stock in lieu of cash for board retainers and fees otherwise payable in cash."}],"balance_after":2090,"source":{"system":"sec-edgar","filing":"0001104659-18-038343","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918038343/a4.xml","form_type":"4"}},{"id":4107969,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T22:01:28.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"10,500 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable. The remaining 20,000 shares will vest 1/12 on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":30500,"derivative":{"exercise_price":1.57,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001144204-18-000856","document":"tv482714_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000856/tv482714_4.xml","form_type":"4"}},{"id":4292936,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Nonqualified Stock Option (right to buy)","published_at":"2017-06-05T18:14:11.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of the one-year anniversary of the date of grant and the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":12000,"derivative":{"exercise_price":149.22,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-17-037535","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917037535/a4.xml","form_type":"4"}},{"id":4292935,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T18:14:11.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person has elected to receive common stock in lieu of cash for board retainers and fees otherwise payable in cash."}],"balance_after":459,"source":{"system":"sec-edgar","filing":"0001104659-17-037535","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917037535/a4.xml","form_type":"4"}},{"id":4503377,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-05T02:41:46.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":28560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8,560 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 20,000 shares will vest 1/12 on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":28560,"derivative":{"exercise_price":2.55,"exercise_date":"2017-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":28560},"source":{"system":"sec-edgar","filing":"0001144204-17-000700","document":"v456175_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420417000700/v456175_4.xml","form_type":"4"}}]}